1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow DaTscan: new trials by email Literature Review of DaTscan trials Research Report on DaTscan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Diagnostic Imaging for Clear Cell Renal Cell Carcinoma Ioflupane I123 - Clear Cell Renal Cell Carcinoma | Phase 2 | Terminated | Region Skane | 5 | 2017-07-14 | 2019-06-21 |
| Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression DaTscan - Parkinson Disease | Phase 2 | Completed | Ken Marek, MD | 952 | 2010-06-01 | 2023-11-14 |
Carcinoma, Renal Cell (1) · Disease (1) · Neurodegenerative Diseases (1) · Parkinson Disease (1)
Ken Marek, MD (1) · Region Skane (1)
Australia (1) · Austria (1) · France (1) · Germany (1) · Greece (1) · Israel (1) · Italy (1) · Norway (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)
Andrew Singleton, PhD (1) · Arthur W. Toga, PhD (1) · Christopher Coffey, PhD (1) · John P Seibyl, MD (1) · John Q. Trojanowski, MD, PhD (1) · Karl Kieburtz, MD (1) · Kenneth L Marek, MD (1) · Peter Elfving, M.D. PhD (1) · Tatiana Froud, PhD (1)
PMID 25710187, PMID 26534930, PMID 28958801, PMID 28986467, PMID 31678032, PMID 32073681, PMID 33790041, PMID 36849448, PMID 37332638, PMID 37451695, PMID 37491235, PMID 37586882, PMID 38169864, PMID 39043465, PMID 39627057, PMID 39644799, PMID 40164470, PMID 40705614, PMID 41094519, PMID 41453126, PMID 42393590
2016 (1)